United States securities and exchange commission logo





                             July 28, 2020

       Steven Morris
       Chief Executive Officer
       BioLife4D Corp
       318 Half Day Road, Suite 201
       Buffalo Grove, IL 60089

                                                        Re: BioLife4D Corp
                                                            Offering Statement
on Form 1-A
                                                            Post-qualification
Offering Circular No. 3
                                                            Filed July 20, 2020
                                                            File No. 024-10779

       Dear Mr. Morris:

             We have reviewed your amendment and have the following comment. In
our comment,
       we may ask you to provide us with information so we may better
understand your disclosure.

              Please respond to this letter by amending your offering statement
and providing the
       requested information. If you do not believe our comment applies to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response. After reviewing any amendment to your offering statement and
the information you
       provide in response to this comment, we may have additional comments.

       Post-qualification Offering Circular No. 3

       Consent of Independent Auditor

   1.                                                   Please file an updated
consent of your independent auditor. Please ensure that the correct
                                                        periods are referenced
in the consent. The periods referred to in the consent should be
                                                        consistent with the
audited financial statements and the dates of the report of your
                                                        independent auditor.
               We will consider qualifying your offering statement at your
request. If a participant in
       your offering is required to clear its compensation arrangements with
FINRA, please have
       FINRA advise us that it has no objections to the compensation
arrangements prior to
       qualification.
 Steven Morris
BioLife4D Corp
July 28, 2020
Page 2

        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

       Please contact Cara Wirth at (202) 551-7127 or Erin Jaskot at (202)
551-3442 with any
questions.



                                                          Sincerely,
FirstName LastNameSteven Morris
                                                          Division of
Corporation Finance
Comapany NameBioLife4D Corp
                                                          Office of Trade &
Services
July 28, 2020 Page 2
cc:       Jillian Sidoti, Esq.
FirstName LastName